Drugs for HER-2-positive Breast Cancer /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Sibilia, Maria. (Editor ), Zielinski, Christoph C. (Editor ), Bartsch, Rupert. (Editor ), Grunt, Thomas W. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Basel : Springer Basel : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Colección:Milestones in Drug Therapy,
Materias:
LEADER 02352nam a22004335i 4500
001 000282019
005 20210504144309.0
007 cr nn 008mamaa
008 110105s2011 sz | s |||| 0|eng d
020 |a 9783034600941 
024 7 |a 10.1007/978-3-0346-0094-1  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Drugs for HER-2-positive Breast Cancer /  |c edited by Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas W. Grunt. 
250 |a 1st ed. 2011. 
260 # # |a Basel :  |b Springer Basel :  |b Imprint: Springer,  |c 2011. 
300 |a X, 110 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Milestones in Drug Therapy, 
505 0 |a Drugs for HER-2-positive Breast Cancer: A Major Approval for Translational Cancer Research (Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas Grunt) -- The EGFR/ErbB family in breast cancer: from signaling to therapy (Wolfgang J. Köstler and Yosef Yarden) -- Trastuzumab as Adjuvant treatment for early stage HER-2 positive breast cancer (Rupert Bartsch and Guenther G. Steger) -- Trastuzumab Resistance in breast cancer (Floriana Morgillo, Michele Orditura, Teresa Troiani, Erika Martinelli, Ferdinando De Vita, Fortunato Ciardiello) -- Treatment with Trastuzumab beyond Progression (Gunter von Minckwitz and Cristina Pirvulescu) -- Pertuzumab - a HER-2 dimerisation inhibitor - for the treatment of breast and other cancers (Giulia Bianchi and Luca Gianni) -- Beyond trastuzumab: Second generation targeted therapies for HER2--positive breast cancer (Flavio F. Solca, Guenther R. Adolf, Hilary Jones, Martina M. Uttenreuther-Fischer). 
650 0 |a Pharmacology. 
650 0 |a Oncology  . 
650 0 |a Cancer research. 
650 0 |a Antibodies. 
650 0 |a Immunology. 
650 0 |a Internal medicine. 
650 1 4 |a Pharmacology/Toxicology. 
650 2 4 |a Oncology. 
650 2 4 |a Cancer Research. 
650 2 4 |a Antibodies. 
650 2 4 |a Immunology. 
650 2 4 |a Internal Medicine. 
700 1 |a Sibilia, Maria.  |e editor. 
700 1 |a Zielinski, Christoph C.  |e editor. 
700 1 |a Bartsch, Rupert.  |e editor. 
700 1 |a Grunt, Thomas W.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks